Romidepsin-DataSheet-生命科學試劑-MedChemExpress

Hotline:400-820-3792Inhibitors?Agonists?ScreeningLibrarieswww.MedChemERomidepsinCat.No.:HY-15149CASNo.:128517-07-7分?式:C??H??N?O?S?分?量:540.7作?靶點:HDAC;Apoptosis作?通路:CellCycle/DNADamage;Epigenetics;Apoptosis儲存?式:Powder-20°C3years*該產(chǎn)品在溶液狀態(tài)不穩(wěn)定，建議您現(xiàn)?現(xiàn)配，即刻使?。溶解性數(shù)據(jù)體外實驗DMSO:50mg/mL(92.47mM;Needultrasonic)掃描?維碼，運?溶解?案計算器獲得適合您實驗體系的溶解?案MassSolvent1mg5mg10mgConcentration制備儲備液1mM1.8495mL9.2473mL18.4945mL5mM0.3699mL1.8495mL3.6989mL10mM0.1849mL0.9247mL1.8495mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度，選擇合適的溶劑配制儲備液；該產(chǎn)品在溶液狀態(tài)不穩(wěn)定，建議您現(xiàn)?現(xiàn)配，即刻使?。體內(nèi)實驗請根據(jù)您的實驗動物和給藥?式選擇適當?shù)娜芙?案。以下溶解?案都請先按照InVitro?式配制澄的儲備液，再依次添加助溶劑：為保證實驗結果的可靠性，澄的儲備液可以根據(jù)儲存條件，適當保存；體內(nèi)實驗的?作液，建議您現(xiàn)?現(xiàn)配，當天使?；以下溶劑前顯?的百分?指該溶劑在您配制終溶液中的體積占?；如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象，可以通過加熱和/或超聲的?式助溶1.請依序添加每種溶劑：10%DMSO40%PEG3005%Tween-8045%salineSolubility:≥2.08mg/mL(3.85mM);Clearsolution此?案可獲得≥2.08mg/mL(3.85mM，飽和度未知)的澄溶液。以1mL?作液為例，取100μL20.8mg/mL的澄DMSO儲備液加到400μLPEG300中，混合均勻；向上述體系中加?50μLTween-80，混合均勻；然后繼續(xù)加?450μL?理鹽?定容?1mL。1/4www.MedChemEwww.MedChemE2.請依序添加每種溶劑：10%DMSO90%(20%SBE-β-CDinsaline)Solubility:≥2.5mg/mL(4.62mM);Clearsolution此?案可獲得≥2.5mg/mL(4.62mM，飽和度未知)的澄溶液。以1mL?作液為例，取100μL25.0mg/mL的澄DMSO儲備液加到900μL20%的SBE-β-CD?理鹽??溶3.液中，混合均勻。請依序添加每種溶劑：10%DMSO90%cornoilSolubility:≥2.5mg/mL(4.62mM);Clearsolution此?案可獲得≥2.5mg/mL(4.62mM，飽和度未知)的澄溶液，此?案不適?于實驗周期在半個?以上的實驗。以1mL?作液為例，取100μL25.0mg/mL的澄DMSO儲備液加到900μL??油中，混合均勻。BIOLOGICALACTIVITY?物活性Romidepsin(FK228)具有抗腫瘤活性的組蛋?去??；?HDAC)抑制劑，抑制HDAC1，HDAC2，HDAC4和HDAC6，IC50值分別為36nM，47nM，510nM和1.4μM。Romidepsin(FK228)由紫?桿產(chǎn)?，誘導G2/M細胞周期阻滯和凋亡(apoptosis)。IC50&TargetHDAC1HDAC2HDAC4HDAC636nM(IC50)47nM(IC50)510nM(IC50)14000nM(IC50)體外研究Romidepsin(0-72hours;0-80nM)inhibitsproliferationofHCCcellsindose-dependentmanner[2].Romidepsin(0-48hours;0-60nM)leadstoatime-anddose-dependentinductionofcellcyclearrestintheG2/MphaseinHCCcells[2].Romidepsin(0-48hours;0-60nM)promotesapoptosisinHCCcells,increasesc-caspase-3,c-caspase-9,andc-PARPproteinexpression[2].CellProliferationAssay[2]CellLine:HCCcellsConcentration:0nM;10nM;20nM;30nM;40nM;50nM;60nM;70nM;80nMIncubationTime:0hours;12hours;24hours;48hours;72hoursResult:InhibitedHCCcellsproliferation.CellCycleAnalysis[2]CellLine:HCCcellsConcentration:0nM;15nM;30nM;60nMIncubationTime:12hours;24hours;48hoursResult:CausedaG2/Marrest.WesternBlotAnalysis[2]2/4www.MedChemEwww.MedChemECellLine:HCCcellsConcentration:0nM;15nM;30nM;60nMIncubationTime:12hours;24hours;48hoursResult:Increaesdc-caspase-3,c-caspase-9,andc-PARPexpressioninHCCcells.體內(nèi)研究Romidepsin(intraperitonealinjection;0.5and1mg/kg;every3day;21days)inhibitedthetumorgrowth,revealsahigherexpressionofp-cdc25C,ki67,c-caspase-3andc-PARP,andalowerexpressionofKi-67inRomidepsintreatedtumors[2].AnimalModel:NudemicewithHuh7cells[2]Dosage:0.5and1mg/kgAdministration:Intraperitonealinjection;0.5and1mg/kg;every3day;21daysResult:Suppressedtumorgrowthinmousexenograftmodels.戶使?本產(chǎn)品發(fā)表的科研?獻?CancerRes.2020Oct15;80(20):4426-4438.?CancerRes.2016Dec1;76(23):7001-7011.?Theranostics.2021Mar20;11(11):5605-5619.?CellDeathDis.2020Sep18;11(9):778.?CellDeathDis.2020Sep15;11(9):753.Seemorecustomervalidationsonwww.MedChemEREFERENCES[1].FurumaiR,etal.FK228(depsipeptide)asanaturalprodrugthatinhibitsclassIhistonedeacetylases.CancerRes.2002Sep1;62(17):4916-21.[2].SunWJ,etal.RomidepsininducesG2/MphasearrestviaErk/cdc25C/cdc2/cyclinBpathwayandapoptosisinductionthroughJNK/c-Jun/caspase3pathwayinhepatocellularcarcinomacells.BiochemPharmacol.2017Mar1;127:90-100.McePdfHeight3/4www.MedChemEwww.MedChemE關注MCE中國公眾號，

獲取前沿資訊、最新活動和

實?科研?具MedChemExpress(MCE)只為有資質的科研機構、醫(yī)